Determination of nucleotide sequence variations through limited primer extension

• US 6,355,433 B1
• Filed: 06/02/2000
• Issued: 03/12/2002
• Est. Priority Date: 06/02/2000
• Status: Expired due to Fees

• Current Assignee: Genaissance Pharmaceuticals Incorporated (Abbvie Incorporated)
• Original Assignee: DNA Sciences, Inc. (Abbvie Incorporated)
• Inventors: Xu, Hua, Glazer, Alexander N.
• Primary Examiner(s): Jones, W. Gary
• Assistant Examiner(s): Taylor, Janell E.
• Application Number:
  US09/586,125
• Time in Patent Office: 648 Days
• Field of Search: 435/6, 435/5, 435/91.1, 435/91.2, 436/536, 436/518
• US Class Current: 435/5
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 2535/125 Allele specific primer extension
• CPC Class Codes: C12Q 2537/157 A reaction step characterised by the number of molecules incorporated or released

Abstract

The present invention provides methods and kits for determining the identity of a nucleotide at a variant site in a target nucleic acid of interest, including, for example, point mutations and single nucleotide polymorphisms. The methods involve conducting template-dependent extension reactions in the presence of a mixture of nucleotides that include at least one labeled extendible nucleotide and at least one labeled non-extendible nucleotide that are selected to be complementary to the nucleotides that potentially occupy the variant site. The particular labeled nucleotide incorporated into the extension products is characteristic of the nucleotide at the variant site. In addition to their utility in analyzing point mutations and single nucleotide polymorphisms, the methods and kits of the invention have utility in a variety of other applications in which specific nucleotide sequence information is of value, including, for example, paternity disputes, prenatal testing, forensic analysis and detection of pathogens.

Claims

1. A method of analyzing a variant site of a target nucleic acid, comprising

(a) conducting a template-dependent extension reaction comprising extending a primer in the presence of the target nucleic acid and a mixture of nucleotides comprising at least one labeled extendible nucleotide and at least one labeled non-extendible nucleotide, each labeled extendible nucleotide and labeled non-extendible nucleotide being complementary to a different allelic form of the target nucleic acid and optionally differentially labeled, wherein the primer hybridizes to a segment of the target nucleic acid such that the 3′

-end of the primer hybridizes adjacent the variant site of the target nucleic acid, whereby

if the labeled extendible nuclcotide is complementary to the nucleotide occupying the variant site, the primer is extended by incorporation of the labeled extendible nucleotide, and can be extended further if one or more nucleotides downstream of the variant site are complementary to one of the nucleotides in the mixture, and

if the labeled non-extendible nucleotide is complementary to the nucleotide occupying the variant site, the primer is extended by incorporation of the labeled non-extendible nucleotide; and

(b) detecting incorporation of labeled nucleotide into the extended primer, the identity of the labeled nucleotide incorporated into the primer indicating the identity of the nucleotide at the variant site, wherein the identity of the incorporated nucleotide is determined from the label borne by the incorporated nucleotide and/or the size of the extended primer.

2. The method of claim 1, wherein the at least one labeled extendible nucleotide is a labeled deoxynucleotide selected from the group consisting of dATP, dTTP, dGTP and dCTP.

3. The method of claim 1, wherein the at least one labeled non-extendible nucleotide is a labeled dideoxynucleotide.

4. The method of claim 1, wherein the at least one labeled extendible nuceleotide is a labeled deoxynucleotide selected from the group consisting of dATP, dTTP, dGTP and dCTP and the at least one labeled non-extendible nucleotide is a labeled dideoxynucleotide.

5. The method of claim 4, wherein the labeled nucleotides are differentially labeled.

6. The method of claim 5, wherein the variant site is a bi-allelic site and the mixture contains a single labeled deoxynucleotide and a single labeled non-extendible nucleotide.

7. The method of claim 5, wherein the variant site is a tri-allelic site and the mixture contains a single labeled deoxynucleotide and two labeled non-extenidible nucleotides.

8. The method of claim 5, wherein the variant site is a tri-allelic site and the mixture contains two labeled deoxynucleotides and a single labeled non-extendible nucleotide.

9. The method of claim 5, wherein the variant site is a tetra-allelic site and the mixture contains a single labeled deoxynuclCotidc and three labeled non-extendible nucleotides.

10. The method of claim 5, wherein the variant site is a tetra-allelic site and the mixture contains two labeled deoxynucleotides and two labeled non-extendible nucleotides.

11. The method of claim 5, wherein the variant site is a tetra-allelic site and the mixture contains three labeled deoxynucleotides and one labeled non-extendible nucleotide.

12. The method of claim 1, wherein the 3′

-end of the primer hybridizes immediately adjacent the variant site.

13. The method of claim 1, wherein the primer extension reaction is conducted under themocycling conditions.

14. The method of claim 1, wherein the label borne by the labeled nucleotides is selected from the group consisting of a fluorophore, a chromophore, a chemiluminescent agent, a radioisotope, an enzyme substrate, an electron dense reagent, a magnetic particle, an electrochemically active moiety and a mass label.

15. The method of claim 14, wherein the label borne by the labeled nucleotides is a fluorescent dye.

16. Thie method according to claim 15, wherein the fluorescent dye is selected from the group consisting of FAM, ROX, TAMRA, R110, R6G, Joe, HEX, TET, Alexa, Cy3 and Cy5.

17. The method of claim 1, wherein extended primer is separated from the labeled nucleotides prior to detecting incorporation of labeled nucleotide into the primer.

18. The method of claim 17, wherein separation is achieved by a size-based separation technique.

19. The method of claim 18, wherein the sized-based separation technique is gel electrophoresis or high performance liquid chromatography.

20. The method of claim 17, wherein extended primer is denatured from the target nucleic acid prior to separating extended primer from the labeled nucleotides.

21. The method of claim 17, wherein the primer bears an attachment moiety that is a first member of a binding pair and separation comprises contacting the primer with a support attached to a second member of the binding pair, whereby the primer becomes immobilized to the support via interaction between the first and second binding pair members.

22. The method of claim 1, wherein the primer bears a primer label different from the labels borne by the labeled nucleotides such that the extended primer bears the primer label and label from the incorporated labeled nucleotide.

23. The method of claim 22, wherein the primer label and the label from the incorporated nucleotide comprise a donor fluorophore and an acceptor fluorophore and detecting comprises detecting a change in fluorescence in the donor and/or acceptor.

24. The method of claim 15, wherein the detection of incorporation is performed by fluorescence polarization.

25. The method of claim 5, wherein

(a) multiple copies of the primer are provided and the target nucleic acid is a first and/or second target nucleic acid contained in a sample from a diploid subject, the first and/or second target nucleic acid differing at the site of variation, whereby if the first target nucleic acid is present, at least one copy of the primer is extended by incorporation of the labeled deoxynucleotide and if the second target nucleic acid is present, at least one copy of the primer is extended by incorporation of the labeled non-extendible nucleotide; and

(b) detecting comprises detecting incorporation of labeled deoxynucleotide and/or labeled non-extenidiblc nticleotide into the primer copies, incorporation of only labeled deoxynuclCotide or labeled non-extendible nucleotide indicating that the subject is a homozygote, whereas incorporation of labeled deoxynucleotide and labeled non-extenidible nucleotide indicate that the subject is a heterozygote.

26. The method of claim 25, wherein the labeled deoxynucleotide and labeled non-extendible nucleotide bear different fluorescent labels that emit at different wavelengths, and detection comprises detection of fluorescence, detection of fluorescence at a single wavelength indicating that the subject is a homozygote and detection of fluorescence at two wavelengths indicating that the subject is a heterozygote.

27. The method of claim 25, wherein:

(a) one or more nuclCotidcs immediately downstream of the variant site of the target nucleic acids are the same as a nuLcleotidc potentially at the variant site and the labeled deoxynucleotidc is selected to be complementary to the one or more downstream nucleotides, whereby if the labeled deoxynucleotidc is complementary to the nucleotide at the variant site of either the first or second target nucleic acid, then the primer is further extended to include additional labeled deoxynuLcleotide such that the first and second target nucleic acid gencerate different sized extension products; and

(b) detecting comprises detecting the presence or absence of different sized extension products.

42. The method of claim 1, wherein detection of incorporated labeled nucleotide is performed without separating labeled nucleotides from extended primer.

28. A method for analyzing variant sites in one or more target nucleic acids, comprising:

(a) conducting a plurality of template-dependent extension reactions in the presence of a plurality of different primers, wherein different primers hybridize adjacent to different variant sites of the one or more target nucleic acids and are differentially labeled, each extension reaction comprising

(i) contacting a sample containing the target nucleic acid(s) with one of the different labeled primers, wherein the 3′

-end of the primer hybridizes adjacent to but not including the variant site of one of the target nucleic acids, and

(ii) exposing the primer to a mixture of nucleotides comprising at least one labeled extendible nuclcotidc and at least one labeled non-extendible nucleotide under conditions whereby

if the labeled extendible nucleotide is complementary to the nucleotide occupying the variant site, the primer is extended by incorporation of labeled extendible nucleotide, and can be extended further if one or more nucleotides downstream of the variant site are complementary to one of the nucleotides in the mixture, and

if the labeled non-extendible nucleotide is complementary to the nucleotide occupying the variant site, the primer is extended by incorporation of labeled non-extendible nucleotide,

whereby the extension reactions generate a plurality of different extension products, extension products generated from different variant sites being distinguishable on the basis of the different labels borne by the extended primers; and

(b) detecting the incorporation of labeled nucleotides into the extension products as an indication of the nucleotides occupying the site of variation in the target nucleic acids, wherein the identity of the incorporated nucleotide is determined from the label borne by the incorporated nucleotide and/or the size of the extended primer.

29. The method of claim 28, wherein the different variant sites are different variant sites on the same target nucleic acid or different sites on different target nucleic acids and the extension reactions are conducted in a single reaction vessel.

30. The method of claim 28, wherein the label borne by the labeled nucleotides and the label borne by labeled primers are selected from the group consisting of a fluorophore, a chromophore, a chemiluminescenit agent, a radioisotope, an enzyme substrate, an electron dense reagent, a magnetic particle, an electrochemically active moiety and a mass label.

31. The method of claim 28, wherein different primers bear different mass labels and detecting comprises separating different extension products according to size.

32. The method of claim 28, wherein

(a) the different labels borne by the different primers are different fluorophores and the labeled nucleotides bear different fluorophores, such that the fluorophores borne by an extension product form a donor and acceptor pair; and

(b) detecting comprises detecting a change in an emission from the donor and/or acceptor for the different donor and acceptor pairs.

33. The method of claim 28, wherein detection is performed by fluorescence polarization.

34. A kit for analyzing a variant site in a target nucleic acid, comprising:

(a) at least one labeled extendible nucleotide and at least one labeled non-extendible nucleotide, the nucleotides complementary to different allelic forms of the target nucleic acid; and

(b) at least one primer, each primer hybridizing to a segment of the target nucleic acid such that the 3′

end of the primer is adjacent the variant site of the target nucleic acid.

35. The kit of claim 34, further comprising a polymerase.

36. The kit of claim 34, wherein the label borne by the labeled nucleotides is a fluorophore.

37. The kit of claim 36, wherein the fluorophore is selected from the group consisting of FAM, ROX, TAMRA, R110, R6G, Joe, HEX, TIETI, Alexa, Cy3 and Cy5.

38. The kit of claim 34, wherein the primer bears a primer label.

39. The kit of claim 38, wherein the primer label is a fluorophore, the fluorophore borne by the nucleotides and the fluorophore borne by the primer comprising donor and acceptor pairs.

40. The kit of claim 34, wherein the primer is at least five primers, each primer hybridizing adjacent a different variant site in the target nucleic acid.

41. The kit of claim 40, wherein each variant site is a site correlated with a disease.

43. A method of analyzing a variant site of a target nucleic acid, comprising:

(a) conducting a template-dependent extension reaction comprising extending a primer in the presence of the target nucleic acid and a mixture of nucleotides comprising at least one labeled extendible nucleotide and at least one labeled non-extendible nucleotide, each labeled extendible nucleotide and labeled non-extendible nucleotide being complementary to a different allelic form of the target nucleic acid and differentially labeled, and wherein the primer hybridizes to a segment of the target nucleic acid such that the 3′

-end of the primer hybridizes adjacent the variant site of the target nucleic acid, whereby

if the labeled extendible nucleotide is complementary to the nucleotide occupying the variant site, the primer is extended by incorporation of the labeled extendible nucleotide, and

if the labeled non-extendible nucleotide is complementary to the nucleotide occupying the variant site, the primer is extended by incorporation of the labeled non-extendible nucleotide; and

(b) detecting incorporation of labeled nucleotide into the extended primer, the identity of the labeled nucleotide incorporated into the primer indicating the identity of the nucleotide at the variant site, wherein the identity of the incorporated nucleotide is determined from the label borne by the incorporated nucleotide.

44. The method of claim 43, wherein the at least one labeled non-extendible nucleotide is a labeled dideoxynucleotide.

45. The method of claim 43, wherein the label borne by the labeled nucleotides is selected from the group consisting of a fluorophore, a chromophore, a chemiluminescent agent, a radioisotope, an enzyme substrate, an electron dense reagent, a magnetic particle, an electrochemically active moiety and a mass label.